Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...

Other pharmas have also put big money into the glue game. In 2024, Eisai signed its own Seed pact worth up to $1.5 billion to go after neurodegeneration and oncology targets.

A new polymer adhesive dissolves when exposed to basic solutions, allowing labels to be easily removed from plastic packaging and improving the quality of recycled plastic. It maintains strong ...